Biology and Life Sciences Medicine and Health Sciences Gene therapy Hematopoiesis IPSC hESC Pluripotent stem cells Tailored nucleases Hematological diseases Stem cells SEVERE COMBINED IMMUNODEFICIENCY HEMATOPOIETIC PROGENITOR CELLS WISKOTT-ALDRICH SYNDROME BLOOD MONONUCLEAR-CELLS HUMAN CORD BLOOD CD34(+) CELLS DIFFERENTIATION CULTURES HUMAN FIBROBLASTS DEFINED FACTORS STROMAL CELLS
Vanhee, Stijn, and Bart Vandekerckhove. “Pluripotent Stem Cell Based Gene Therapy for Hematological Diseases.” CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 97 (2015): 238–246. Print.
Vanhee, S., & Vandekerckhove, B. (2015). Pluripotent stem cell based gene therapy for hematological diseases. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 97, 238–246.
Vanhee, Stijn, and Bart Vandekerckhove. 2015. “Pluripotent Stem Cell Based Gene Therapy for Hematological Diseases.” Critical Reviews in Oncology Hematology 97: 238–246.
Vanhee S, Vandekerckhove B. Pluripotent stem cell based gene therapy for hematological diseases. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2015;97:238–46.
TY - JOUR
UR - http://lib.ugent.be/catalog/pug01:8506269
ID - pug01:8506269
LA - eng
TI - Pluripotent stem cell based gene therapy for hematological diseases
PY - 2015
JO - (2015) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
SN - 1040-8428
PB - 2015
AU - Vanhee, Stijn UGent 002004020097 802000615984
AU - Vandekerckhove, Bart GE32 UZGent
All data below are available with an Open Data Commons Open Database License. You are free to copy, distribute and use the database; to produce works from the database; to modify, transform and build upon the database. As long as you attribute the data sets to the source, publish your adapted database with ODbL license, and keep the dataset open (don't use technical measures such as DRM to restrict access to the database). The datasets are also available as weekly exports.